LONDON and NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — OKYO Pharma Limited (Nasdaq: OKYO), a clinical-stage biopharmaceutical company developing investigational therapies for the treatment of neuropathic corneal pain (NCP) and for inflammatory eye diseases, today announced the pricing of an underwritten public offering (the “Offering”) of 10,815,000 ordinary shares at an offering price of $1.85 per ordinary share. The Company has granted the underwriter a 30-day option to purchase up to an additional 1,622,250 ordinary shares at the public offering price, less underwriting discounts and commissions. The gross proceeds to the Company from the Offering, before deducting offering expenses payable by the Company and discounts, will be approximately $20 million. Assuming full exercise by the underwriter of its option to purchase additional...

BEIJING, Feb. 12, 2026 (GLOBE NEWSWIRE) — InnoCare Pharma (HKEX: 9969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first patient has been dosed in the Phase II/III clinical trial of novel TYK2 inhibitor soficitinib (ICP-332) for the treatment of chronic spontaneous urticaria (CSU). Currently, patient enrollment has been completed in the Phase III registrational clinical trial of soficitinib for the treatment of moderate to severe atopic dermatitis (AD), and in the Phase II clinical trial for the treatment of vitiligo. In addition, clinical trials of soficitinib for the treatment of psoriasis and nodular prurigo are also progressing rapidly. Soficitinib is a potent and selective TYK2 inhibitor that is being developed for the treatment of...

REDWOOD CITY, Calif., Feb. 12, 2026 (GLOBE NEWSWIRE) — Coherus Oncology, Inc. (“Coherus” or the “Company”) (NASDAQ: CHRS), today announced the pricing of an underwritten public offering of 28,600,000 shares of the Company’s common stock (the “Offering”). The shares of common stock are being sold at a public offering price of $1.75 per share, before underwriting discounts and commissions. All of the shares in the Offering are being sold by the Company. The gross proceeds to Coherus from the Offering are expected to be approximately $50.1 million, before deducting underwriting discounts and commissions and other offering expenses. The Company has granted the underwriters of the Offering a 30-day option to purchase up to an additional 4,290,000 shares of common stock at the public offering price, less the underwriting discounts and...

VANCOUVER, British Columbia, Feb. 12, 2026 (GLOBE NEWSWIRE) — EnWave Corporation (TSX-V:ENW | FSE:E4U) (“EnWave”, or the “Company”) announced today it will report its financial results for the first quarter ended December 31, 2025 on Thursday, February 19, 2026 after market close. The financial statements and MD&A will be available on SEDAR at www.sedarplus.ca and on the Company’s website. The Company has scheduled a conference call to discuss the results for Q1 2026 and business outlook on Friday, February 20, 2026 at 7:00 a.m. Pacific Time (10:00 a.m. Eastern Time). Brent Charleton, Chief Executive Officer and Dylan Murray, Chief Financial Officer will present EnWave’s results and host a question and answer period. Conference Call Details:Date: February 20, 2026Time: 7:00am PST / 10:00am ESTParticipant...

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — Namib Minerals (“Namib Minerals” or “the Company”), (Nasdaq: NAMM), today provided an update on progress at its Redwing Mine in Zimbabwe, confirming that dewatering activities commenced on January 29, 2026, in line with the work plan outlined in the Company’s November 2025 business update. The dewatering phase will enable access to the mine for feasibility studies, including underground condition assessments and detailed engineering evaluations, which will inform the next stages of the restart project at Redwing. The Company noted that progress to date is consistent with the planned enabling works and reflects the Company’s disciplined, safety-focused approach to restarting production at the Redwing Mine. “Dewatering at Redwing is progressing as planned and represents an important milestone...

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — IREN Limited (NASDAQ: IREN) (“IREN”) today announced it will be added to the MSCI USA Index, effective after close of trading on February 27, 2026. The MSCI USA Index measures the performance of large and mid cap segments of the U.S. equity market and represents approximately 85% of the free float-adjusted market capitalization in the US. This inclusion is expected to enhance IREN’s visibility among institutional investors and index-tracking funds. Daniel Roberts, Co-Founder and Co-CEO of IREN, commented: “Being added to the MSCI USA Index reflects the scale and liquidity we have built in the business. We believe this milestone will broaden institutional access to IREN as we continue to execute on our AI Cloud strategy.” About IREN IREN is a leading AI Cloud Service Provider, delivering...

BRISBANE, Australia, Feb. 12, 2026 (GLOBE NEWSWIRE) — Aura FAT Projects Acquisition Corp (“AFAR”), a special purpose acquisition company, and Dalmore Holdings Pty Ltd (“Dalmore”) have entered into a binding Letter of Intent (“LOI”) in connection with a proposed business combination. Upon completion, the combined company is expected to be publicly listed on a national securities exchange in the United States. Under the terms of the LOI, all existing Dalmore shareholders are to roll their equity into the combined company. In connection with the proposed transaction, AFAR expects to raise additional capital through a private investment in public equity (“PIPE”) financing to support the combined company’s growth objectives and future development plans. The LOI is subject to completion of due diligence and final transaction structuring,...

CHATTANOOGA, Tenn., Feb. 12, 2026 (GLOBE NEWSWIRE) — NOVONIX Limited (NASDAQ: NVX, ASX: NVX) (“NOVONIX” or the “Company”), today acknowledged the U.S. Department of Commerce’s (“Commerce”) final determinations in the antidumping and countervailing duty investigations covering anode active materials (“AAM”) imported into the U.S. from China. The total amount of the tariffs applicable to AAM imported from China will be at least 160%, subject to a final affirmative determination by the U.S. International Trade Commission (“ITC”) that the U.S. AAM industry has been materially impeded because of Chinese AAM imports. The ITC’s final determination is expected in March 2026. HighlightsSubject to the ITC’s final determination on material impediment:An antidumping duty of 93.5% will be imposed on AAM imports from China from specified companies...

NEW YORK, Feb. 12, 2026 (GLOBE NEWSWIRE) — 21shares, one of the world’s largest issuers of cryptocurrency exchange traded products (ETPs), today announced the following distribution for the 21shares Solana ETF (TSOL) for staking rewards earned from its SOL holdings.Ticker Name Distribution Ex/Record Date Payable DateTSOL 21shares Solana ETF $0.316871 per share February 13, 2026 February 17, 2026About 21shares 21shares is one of the world’s leading cryptocurrency exchange traded product (ETP) providers and offers one of the largest suites of crypto ETPs in the market. The company was founded to make cryptocurrency more accessible to investors, and to bridge the gap between traditional finance and decentralized finance. 21shares listed the world’s first physically-backed crypto ETP in 2018, building a seven-year track record...

• Conference to be held in Hollywood, Florida from February 22 to 25, 2026 TORONTO, Feb. 12, 2026 (GLOBE NEWSWIRE) — Q-Gold Resources Ltd. (TSXV: QGR; OTCQB: QGLDF; Börse Frankfurt: QX9G) (“QGold” or the “Company”) is pleased to announce that it has been invited to attend the BMO Global Metals, Mining & Critical Minerals Conference. BMO Capital Markets will host its 35th annual Global Metals, Mining & Critical Minerals Conference in Hollywood, Florida on February 22 – 25. Celebrating thirty-five years this year, BMO’s Global Metals, Mining and Critical Minerals Conference brings together senior leaders, global investors, policymakers, and analysts for three days of strategic insights and industry‑defining conversations. Spanning four decades, this conference has become one of the world’s leading forums for...